TickerFactsScreenerDevelopers

Xenon Pharmaceuticals Inc. (XENE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$86.32M2012: -$89.86M2013: -$78.37M2014: $72.78M2015: $61.03M2016: $63.90M2017: $35.93M2018: $103.30M2019: $91.98M2020: $171.35M2021: $550.03M2022: $721.50M2023: $927.92M2024: $754.90M2025: $581.76M$581.76M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$581.76M-22.9%
2024$754.90M-18.6%
2023$927.92M+28.6%
2022$721.50M+31.2%
2021$550.03M+221.0%
2020$171.35M+86.3%
2019$91.98M-11.0%
2018$103.30M+187.5%
2017$35.93M-43.8%
2016$63.90M+4.7%
2015$61.03M-16.1%
2014$72.78M+192.9%
2013-$78.37M+12.8%
2012-$89.86M-4.1%
2011-$86.32M—